Difference between revisions of "CARv3-TEAM-E T-cells"
Jump to navigation
Jump to search
m |
m |
||
| Line 4: | Line 4: | ||
==Preliminary data== | ==Preliminary data== | ||
===[[Glioblastoma]]=== | ===[[Glioblastoma]]=== | ||
| − | #'''INCIPIENT:''' Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT, Gallagher K, Maus MV. Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma. N Engl J Med. 2024 Apr 11;390(14):1290-1298. Epub 2024 Mar 13. [https://doi.org/10.1056/nejmoa2314390 link to original article] [https://pubmed.ncbi.nlm.nih.gov/38477966/ PubMed] [https://clinicaltrials.gov/study/NCT05660369 NCT05660369] | + | #'''INCIPIENT:''' Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT, Gallagher K, Maus MV. Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma. N Engl J Med. 2024 Apr 11;390(14):1290-1298. Epub 2024 Mar 13. [https://doi.org/10.1056/nejmoa2314390 link to original article] [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11162836/ link to PMC article] [https://pubmed.ncbi.nlm.nih.gov/38477966/ PubMed] [https://clinicaltrials.gov/study/NCT05660369 NCT05660369] |
[[Category:Anti-EGFRvIII CAR T-cells]] | [[Category:Anti-EGFRvIII CAR T-cells]] | ||
[[Category:Glioblastoma medications (investigational)]] | [[Category:Glioblastoma medications (investigational)]] | ||
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
Latest revision as of 11:54, 6 July 2024
Mechanism of action
anti-EGFR variant III CAR T-cells
Preliminary data
Glioblastoma
- INCIPIENT: Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT, Gallagher K, Maus MV. Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma. N Engl J Med. 2024 Apr 11;390(14):1290-1298. Epub 2024 Mar 13. link to original article link to PMC article PubMed NCT05660369